Abstract
This chronicle of psoriasis begins in ancient times when psoriasis, leprosy, and other inflammatory skin disorders were thought to be the same condition. The identification of psoriasis as a distinct entity did not occur until the 19th century, when clinical descriptions distinguished it from other cutaneous disorders. Histopathologic descriptions in the 1960s and 1970s shed some light on the pathophysiology of psoriasis, but many aspects of the disease remain unknown to this day. As Bechet expressed, “Psoriasis is an antidote for dermatologists’ ego” [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bechet PE (1936) Psoriasis, a brief historical review. Arch Dermatol Syph 33: 327–334
Hebra F (1868) On disease of the skin. New Sydenham Society, London
Fox H (1915) Dermatology of the ancients. JAMA 65: 469
Sutton RL (1986) Sixteenth century physician and his methods mercurialis on diseases of the skin. The Lowell Press, Kansas City, MO
Pusey WA (1933) The history of dermatology. Charles C Thomas, Springfield, IL
Glickman FS (1986) Lepra, psora, psoriasis. J Am Acad Dermatol 14(5 Pt 1): 863–866
Celsus AC (1837) De re medica. East Portwine, London
Willan, R (1809) On Cutaneous Diseases. Kimber and Conrad, Philadelphia
Rayer P (1835) Treatises on diseases of the skin. 2nd ed. J.B. Bailliere, London
Gibert CM (1840) Traite pratique des maladies speciales de la peau. 2nd ed. Germer-Bailliere, Paris
Wilson E (1863) Diseases of the skin. Blanchchard and Lea, Philadelphia
Fox T (1871) Skin diseases: Their description, pathology, diagnosis, and treatment. William Wood and Co, New York
Milton JL (1872) Diseases of the skin. Robert Hardwicke, London
Crissey JT, Parish LC, Shelley WB (1981) The dermatology and syphilology of the nineteenth century. Praiger Publishers, New York
Hebra on F, Kaposi M (1876) Lehrbuch der Hautkrankheiten. Ferdinanand Euke, Stuttgart
Fry L (1988) Psoriasis. Br J Dermatol 119(4): 445–461
Farber EM (1982) Historical Commentary. In: EM Farber, AJ Cox, L Nall, PH Jacobs (eds): Psoriasis: proceedings of the Third International Symposium, Stanford University, 1981. Third ed. Grune and Stratton, New York, 7–11
Köbner H (1876) Zur Aetiologie der Psoriasis. Vjschr Dermatol 3: 559–561
von Zumbusch LR (1910) Psoriasis und pustuloses exanthem. Archives of Dermatology and Syphiliology 99: 335–346
Woronoff DL (1926) Die peripheren Veränderungen der Haut um die Effloreszenzen der Psoriasis vulgaris und Syphilis corymbosa. Dermatologische Wochenschrift 82: 249–257
VanScott EJ, Ekel TM (1963) Kinetics of hyperplasia in psoriasis. Arch Dermatol 88: 373–381
Weinstein GD, Van Scott EJ (1966) Turnover time of human normal and psoriatic epidermis by autoradiographic analysis. J Inves Dermatol 45: 561–567
Gubner R (1951) Effect of aminopterin on epithelial tissues. AMA Arch Derm Syphilol 64(6): 688–699
Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis. N Engl J Med 301(10): 555
Bjerke JR, Krogh HK, Matre R (1978) Characterization of mononuclear cell infiltrates in psoriatic lesions. J Invest Dermatol 71(5): 340–343
Baker BS, Swain AF, Fry L, Valdimarsson H (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110(5): 555–564
Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352(18): 1899–1912
Girdlestone T (1806) Observations on the effects of Dr. Fowler’s mineral solution in lepra and other diseases. Med Phys J London 15: 298–301
Farber EM (1992) History of the treatment of psoriasis. J Am Acad Dermatol 27(4): 640–645
Duhring LA (1876) Atlas of skin diseases. JB Lippincot and Co, Philadelphia
Squire B (1876) Treatment of psoriasis by an ointment of chrysophanic acid. BMJ 819–920
Unna PG (1916) Cignolin als Heilmittel der Psoriasis. Dermatologische Wochenschrift 6: 116–137, 151–163, 175–183
Hjorth N, Norgaard M (1991) Tars. In: HH Roenigk, HL Maibach (eds): Psoriasis. Marcel Dekker, New York, 473–479
Squire B (1878) Atlas of skin diseases. JandA Churchill, London
Goeckerman WH (1925) The treatment of psoriasis. Northwest Med 25: 229–231
Ingram JT (1953) The approach to psoriasis. BMJ 2: 591–593
Lundberg IE, Grundtman C, Larsson E, Klareskog L (2004) Corticosteroids — from an idea to clinical use. Best Pract Res Clin Rheumatol 18(1): 7–19
Hench PS, Kendall EC, Slocumb CH, Polley HF (1950) Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Med Interna 85(4): 545–666
Sulzberger MB, Witten VH (1952) The effect of topially applied compound F in selected dermatoses. J Invest Dermatol 19: 101–102
Farber S, Diamond L, Mercer R, Sylvester R, Wolff V (1946) Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-amethopteroylglutamic acid (aminopterin). N Engl J Med 238: 787–793
Edmundson WF, Guy WB (1958) Treatment of psoriasis with folic acid antagonists. AMA Arch Derm 78(2): 200–203
Roenigk HH Jr, Maibach HI, Weinstein GD (1973) Use of methotrexate in psoriasis. Arch Dermatol 105(3): 363–365
Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA (1974) Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291(23): 1207–1211
Benedetto AV (1977) The psoralens: An historical perspective. Cutis 20: 469–471
Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 68(6): 328–335
Fischer T, Alsins J (1976) Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol 383–390
Parrish JA, Jaenicke KF (1981) Action spectrum for phototherapy of psoriasis. J Invest Dermatol 76: 359–361
Green C, Ferguson J, Lakshmipathi T, Johnson BE (1988) 311 nm UVB phototherapy — an effective treatment for psoriasis. Br J Dermatol 119(6): 691–696
Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J (1992) Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 127(5): 509–512
Wolbach SB, Howe PR (1925) Tisse changes following deprivation of fat-solbe A-vitamin. J Experimental Med 42: 753–778
Stuttgen G (1962) Zur Lokalbehandlung von Keratosen mit Vitamin A-Säure. Dermatologica 124: 65–80
Tsambaos D, Orfanos CE (1981) Chemotherapy of psoriasis and other skin disorders with oral retinoids. Pharmacol Ther 14(3): 355–374
Ward A, Brogden RN, Heel RC, Speight TM, Avery GS (1984) Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs 28(1): 6–37
Ellis CN, Voorhees JJ (1987) Etretinate therapy. J Am Acad Dermatol 16(2, Part 1): 267–291
Weinstein GD (1996) Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Br J Dermatol 135Suppl 49: 32–36
Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 35(3–4): 51–54
Smith EL, Walworth NC, Holick MF (1986) Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86(6): 709–714
Kragballe K, Wildfang IL (1990) Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 282(3): 164–167
Kragballe K, Beck HI, Sogaard H (1988) Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br J Dermatol 119(2): 223–230
Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6(4): 468–475
Griffiths CE, Dubertret L, Ellis CN, Finlay AY, Finzi AF, Ho VC, Johnston A, Katsambas A, Lison AE, Naeyaert JM et al. (2004) Ciclosporin in psoriasis clinical practice: An international consensus statement. Br J Dermatol 150Suppl 67: 11–23
Ellis CN, Krueger GG (2001) Alefacept Clinical Study Group. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345(4): 248–255
Kupper TS (2003) Immunologic targets in psoriasis. N Engl J Med 349(21): 1987–1990
Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB, Etanercept Psoriasis Study Group (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349(21): 2014–2022
Lebwohl MG (2005) Advances in psoriasis. Arch Dermatol 141(12): 1589–1590
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Cowden, A., Van Voorhees, A.S. (2008). Introduction: History of psoriasis and psoriasis therapy. In: Weinberg, J.M. (eds) Treatment of Psoriasis. Milestones in Drug Therapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7724-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-7643-7724-3_1
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7722-9
Online ISBN: 978-3-7643-7724-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)